Amanote Research
Register
Sign In
Letter: Antiemetics for High-Dose Cyclophosphamide.
BMJ
doi 10.1136/bmj.1.5949.95-e
Full Text
Open PDF
Abstract
Available in
full text
Date
January 11, 1975
Authors
P J Kearney
Publisher
BMJ
Related search
High-Dose Cyclophosphamide Versus Monthly Intravenous Cyclophosphamide for Systemic Lupus Erythematosus: A Prospective Randomized Trial
Arthritis & Rheumatism
High Dose, Dose-Intensive Chemotherapy With Doxorubicin and Cyclophosphamide for the Treatment of Advanced Breast Cancer
British Journal of Cancer
Cancer Research
Oncology
Rebooting the Immune System With High-Dose Cyclophosphamide for Treatment of Refractory Myasthenia Gravis
Annals of the New York Academy of Sciences
Genetics
Molecular Biology
Biochemistry
Neuroscience
History
Philosophy of Science
High-Dose Cyclophosphamide Without Stem Cell Rescue in Immune-Mediated Necrotizing Myopathies
Neurology: Neuroimmunology and NeuroInflammation
Neurology
Hematopoietic Stem Cell Transplantation for Childhood Myeloid Malignancies After High-Dose Thiotepa, Busulfan and Cyclophosphamide
Bone Marrow Transplantation
Transplantation
Hematology
Post Transplantation High-Dose Cyclophosphamide (PTCy) to Promote Immune Tolerance After Reconstructive Transplantation
Vascularized Composite Allotransplantation
Treatment of Hematological Malignancies With Nonmyeloablative, HLA-haploidentical Bone Marrow Transplantation and High Dose, Post-Transplantation Cyclophosphamide
Best Practice and Research in Clinical Haematology
Oncology
Clinical Biochemistry
High-Dose Cyclophosphamide Does Not Eradicate Paroxysmal Nocturnal Haemoglobinuria Haematopoiesis in Mice Carrying a Piga Gene Mutation
British Journal of Haematology
Hematology
Heparin for Coronary Angioplasty: High Dose, Low Dose, or No Dose?
Heart
Cardiovascular Medicine
Cardiology
